Persistent Visual Impairment in pwMS - Stage 3
Research type
Research Study
Full title
Persistent Visual Impairment in Multiple Sclerosis - Stage Three: an exploratory study investigating visual function and impact on general function and balance in people with Multiple Sclerosis.
IRAS ID
229363
Contact name
Rachel McKay
Contact email
Sponsor organisation
Glasgow Caledonian University
Duration of Study in the UK
0 years, 6 months, 28 days
Research summary
Impaired visual function is one of the most common problems experienced by people with MS (pwMS) and can present in many ways including sudden loss of vision, blurred, double or wobbly vision, loss of colour vision or visual field loss.
To date, most studies have examined pwMS in the acute phases of the disease but little was known on persistent visual problems. The first two stages of our study found that pwMS had a higher rate of self-reported visual impairment than a non-MS population and that contrast sensitivity function (CSF) in particular was lower in pwMS.
For Stage Three, a small cohort identified as having CSF below clinical norms and who reported visual impairment impacting on daily life will be invited to attend GCU for further testing to enrich our knowledge on how, if at all, this reduction in contrast sensitivity function impacts on daily life using measures of general function and balance.
REC name
West of Scotland REC 5
REC reference
17/WS/0162
Date of REC Opinion
22 Aug 2017
REC opinion
Favourable Opinion